Latest Leadership Changes News

Atomos Limited faced a challenging Q4 FY25 with US tariff disruptions but rebounded strongly in June, launching new products and appointing Peter Barber as CEO to drive future growth.

Cobalt Blue Holdings has completed a promising scoping study for its Halls Creek copper-zinc-silver project and secured a key cobalt feedstock contract with Glencore, setting the stage for a final investment decision on its Kwinana Cobalt Refinery by year-end.

High-Tech Metals has completed a transformative acquisition of the Mt Fisher and Mt Eureka gold projects, expanding its footprint in Western Australia's Northern Goldfields and setting the stage for aggressive exploration and early production.

Marquee Resources has progressed its Mt Clement antimony-gold project with Phase 1 drilling completed and assay results pending, alongside a $596,000 capital raise and a key executive appointment.

QEM Limited has appointed Robert Cooper as its new CEO and secured $2.05 million in funding, while progressing key regulatory and technical milestones for its Julia Creek Vanadium and Energy Project.

Mithril Silver and Gold Limited reports strong exploration progress in Mexico’s Copalquin District with high-grade gold and silver assay results and a successful C$11.5 million private placement.

Ramelius Resources has finalized its acquisition of Spartan Resources, issuing new shares and cash to Spartan shareholders while expanding its board and asset portfolio. This move aims to accelerate Ramelius' growth toward becoming a half-million ounce gold producer within five years.

Lord Resources announces the resignation of CEO Andrew Taylor as exploration at the Ilgarari Copper Project advances under Georgina Clark’s management.

InteliCare Holdings advances its AI-driven aged care platform with new trials and integrations, secures $1 million in funding, and announces CEO Daniel Pilbrow’s upcoming resignation.

MedAdvisor Solutions reported a 16.6% revenue decline in 4Q FY25, driven by US market challenges, while completing the sale of its ANZ business and initiating a strategic review of its US operations.

EVE Health Group has completed its acquisition of Nextract, raised $1 million to fund manufacturing, and achieved key regulatory and commercial milestones for its pharmaceutical products targeting erectile dysfunction and dysmenorrhea.

Janus Electric Holdings has relaunched on the ASX, securing $8.8 million to accelerate its heavy vehicle electrification strategy, including a key supply agreement with Electrovaya for next-generation lithium-ion batteries.